Voyager Therapeutics, Inc. (VYGR) › Shareholders' EquityVoyager Therapeutics, Inc. (VYGR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2013: -$3.83M2014: -$20.83M2015: $169.07M2016: $135.92M2017: $134.05M2018: $46.45M2019: $99.51M2020: $154.32M2021: $95.06M2022: $59.02M2023: $236.32M2024: $299.76M2025: $196.08M$196.08M2013Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$196.08M-34.6%2024$299.76M+26.8%2023$236.32M+300.4%2022$59.02M-37.9%2021$95.06M-38.4%2020$154.32M+55.1%2019$99.51M+114.3%2018$46.45M-65.4%2017$134.05M-1.4%2016$135.92M-19.6%2015$169.07M+911.7%2014-$20.83M-443.4%2013-$3.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share